Intercure (Israel) Performance
| INCR Stock | ILS 501.70 16.90 3.49% |
The company retains a Market Volatility (i.e., Beta) of 0.87, which attests to possible diversification benefits within a given portfolio. Intercure returns are very sensitive to returns on the market. As the market goes up or down, Intercure is expected to follow. At this point, Intercure has a negative expected return of -0.73%. Please make sure to check out Intercure's skewness, accumulation distribution, and the relationship between the potential upside and kurtosis , to decide if Intercure performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Intercure has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 37.9 M | |
| Total Cashflows From Investing Activities | -65.2 M |
Intercure |
Intercure Relative Risk vs. Return Landscape
If you would invest 71,530 in Intercure on September 18, 2024 and sell it today you would lose (21,360) from holding Intercure or give up 29.86% of portfolio value over 90 days. Intercure is generating negative expected returns and assumes 3.3744% volatility on return distribution over the 90 days horizon. Simply put, 30% of stocks are less volatile than Intercure, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Intercure Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Intercure's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Intercure, and traders can use it to determine the average amount a Intercure's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2161
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INCR |
Estimated Market Risk
| 3.37 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.73 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.22 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Intercure is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Intercure by adding Intercure to a well-diversified portfolio.
Intercure Fundamentals Growth
Intercure Stock prices reflect investors' perceptions of the future prospects and financial health of Intercure, and Intercure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Intercure Stock performance.
| Return On Equity | 0.0736 | |||
| Return On Asset | 0.0538 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 688.06 M | |||
| Shares Outstanding | 45.57 M | |||
| Price To Earning | 590.59 X | |||
| Price To Book | 1.43 X | |||
| Price To Sales | 1.87 X | |||
| Revenue | 219.68 M | |||
| EBITDA | 31.18 M | |||
| Cash And Equivalents | 3.66 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 11.95 M | |||
| Debt To Equity | 64.90 % | |||
| Book Value Per Share | 10.75 X | |||
| Cash Flow From Operations | 25.02 M | |||
| Earnings Per Share | 0.74 X | |||
| Total Asset | 686.32 M | |||
| Retained Earnings | (35 M) | |||
| Current Asset | 1000 K | |||
| Current Liabilities | 1000 K | |||
About Intercure Performance
By analyzing Intercure's fundamental ratios, stakeholders can gain valuable insights into Intercure's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Intercure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Intercure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
InterCure Ltd. invests in the biomedical, life sciences, and biotechnology sectors in Israel and internationally. InterCure Ltd. was founded in 1994 and is based in Hadera, Israel. INTERCURE LTD is traded on Tel Aviv Stock Exchange in Israel.Things to note about Intercure performance evaluation
Checking the ongoing alerts about Intercure for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Intercure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Intercure generated a negative expected return over the last 90 days | |
| Intercure has high historical volatility and very poor performance | |
| The company has S11.95 Million in debt which may indicate that it relies heavily on debt financing | |
| Intercure has accumulated 11.95 M in total debt with debt to equity ratio (D/E) of 64.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Intercure has a current ratio of 0.3, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Intercure until it has trouble settling it off, either with new capital or with free cash flow. So, Intercure's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Intercure sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Intercure to invest in growth at high rates of return. When we think about Intercure's use of debt, we should always consider it together with cash and equity. | |
| About 38.0% of Intercure shares are held by company insiders |
- Analyzing Intercure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Intercure's stock is overvalued or undervalued compared to its peers.
- Examining Intercure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Intercure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Intercure's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Intercure's stock. These opinions can provide insight into Intercure's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Intercure Stock analysis
When running Intercure's price analysis, check to measure Intercure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intercure is operating at the current time. Most of Intercure's value examination focuses on studying past and present price action to predict the probability of Intercure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intercure's price. Additionally, you may evaluate how the addition of Intercure to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |